六水六氟硅酸镁, 99%,Magnesium hexafluorosilicate hexahydrate
产品编号:西域试剂-WR365238| CAS NO:18972-56-0| MDL NO:MFCD00150250| 分子式:F6H12MgO6Si| 分子量:274.47
本网站销售的所有产品仅用于工业应用或者科学研究等非医疗目的,不可用于人类或动物的临床诊断或者治疗,非药用,非食用,
英文名称 | Magnesium hexafluorosilicate hexahydrate |
---|---|
CAS编号 | 18972-56-0 |
产品熔点 | 120°C (dec.) |
产品沸点 | 100ºC at 760 mmHg |
产品密度 | 1,79 g/cm3 |
精确质量 | 183.96300 |
PSA | 9.23000 |
LogP | 2.07610 |
外观性状 | 结晶白色,有淡香味的颗粒 |
稳定性 | 1.常温常压下稳定 2.避免的物料:水分/潮湿 酸 |
储存条件 | 常温密闭避光,通风干燥 |
相关文档
化学品安全说明书(MSDS)
下载MSDS质检证书(COA)
相关产品
风险声明 (欧洲) | R25 |
---|---|
安全声明 (欧洲) | S24/25-S45 |
危险品运输编码 | 2853 |
包装等级 | III |
危险类别 | 6.1 |
Section 1: Product Identification Chemical Name:Magnesium hexafluorosilicate hexahydrate, 98% CAS Registry Number:18972-56-0 Formula:MgSiF6.6H2O EINECS Number:none Chemical Family:halometallate salts Synonym:Magnesium fluorosilicate, Magnesium silicofluoride
Section 2: Composition and Information on Ingredients IngredientCAS NumberPercentACGIH (TWA)OSHA (PEL) Title compound18972-56-0100%2.5mg/m3 (as F)2.5mg/m3 (as F) Section 3: Hazards Identification Irritating to eyes, skin, and respiratory tract. Harmful if swallowed. If inhaled or swallowed, this compound may, Emergency Overview:to the extent that it may form water soluble fluoride, cause fluoride poisoning. Early symptoms include nausea, vomiting, diarrhea, and weakness Primary Routes of Exposure:Contact with skin and eyes. Inhalation of dust. Eye Contact:Causes irritation and may cause serious eye damage. Effects may not immediately appear. Causes irritation, with redness and pain. Soluble fluoride may be corrosive. Effects may not appear Skin Contact: immediately Inhalation of dust causes severe irritation to the respiratory tract, causing coughing, sore throat, and labored Inhalation: breathing. Ingestion:Harmful if swallowed. May cause salivation, nausea, vomiting, diarrhea, and abdominal pain. Irritating to eys, skin and respiratory tract. Dust: Fluoride poisoning may cause nausea, vomiting, diarrhea, Acute Health Affects: weakness, coma, respiratory failure and cardiovascular collapse. Chronic Health Affects:Prolonged exposure to hydrolysable fluorine compounds can cause deterioration of bone and tooth structure. NTP:No IARC:No OSHA:No SECTION 4: First Aid Measures Immediately flush the eyes with copious amounts of water for at least 10-15 minutes. A victim may need Eye Exposure: assistance in keeping their eye lids open. Get immediate medical attention. Wash the affected area immediately with water. Remove contaminated clothing if necessary. Seek medical Skin Exposure: assistance if irritation persists. Remove the victim to fresh air. Closely monitor the victim for signs of respiratory problems, such as difficulty Inhalation: in breathing, coughing, wheezing, or pain. In such cases seek immediate medical assistance. Seek medical attention immediately. Keep the victim calm. Give the victim water (only if conscious). Induce Ingestion: vomiting only if directed by medical personnel. SECTION 5: Fire Fighting Measures Flash Point:not applicable Autoignition Temperature:none Explosion Limits:none Extinguishing Medium:None. Material is non-flammable. If this product is involved in a fire, fire fighters should be equipped with a NIOSH approved positive pressure Special Fire Fighting Procedures: self- contained breathing apparatus and full protective clothing. Hazardous Combustion andIf involved in a fire this material may emit corrosive fumes of hydrofluoric acid. Decomposion Products: Unusual Fire or Explosion Hazards: No unusual fire or explosion hazards. SECTION 6: Accidental Release Measures Small spills can be mixed with powdered sodium bicarbonate, lime, or calcium carbonate and swept up. Avoid Spill and Leak Procedures:raising dust. Spillage in areas not adequately ventilated may require an evacuation of area. Emergency response teams will require self-contained breathing apparatus. SECTION 7: Handling and Storage Handling and Storage:Store in a tightly sealed non-glass container away from moisture. SECTION 8: Exposure Controls and Personal Protection Eye Protection:Always wear approved safety glasses when handling a chemical substance in the laboratory. Skin Protection:Wear protective clothing and gloves. Consult with glove manufacturer to determine the proper type of glove. Ventilation:Solid may form a toxic fine dust. If possible, handle the solid in an efficient fume hood. If in form of fine dust and ventilation is not available a respirator should be worn. The use of respirators Respirator: requires a Respirator Protection Program to be in compliance with 29 CFR 1910.134. Ventilation:Solid may form a toxic fine dust. If possible, handle the solid in an efficient fume hood. Additional Protection:No additional protection required. SECTION 9: Physical and Chemical Properties Color and Form:white pwdr. Molecular Weight:166.39 (274.48) Melting Point:no data Boiling Point:no data Vapor Pressure:no data Specific Gravity:1.788 Odor:none Solubility in Water:soluble SECTION 10: Stability and Reactivity Stability:air and moisture stable Hazardous Polymerization:no hazardous polymerization Conditions to Avoid:none Incompatibility:active metals Decomposition Products:hydrogen fluoride, magnesium fluoride and silicon fluorides SECTION 11: Toxicological Information RTECS Data:Oral (guinea pig); LD50:200 mg/kg. Subcutaneous (frog); LDLo:420 mg/kg. Carcinogenic Effects:no data Mutagenic Effects:no data Tetratogenic Effects:no data SECTION 12: Ecological Information Ecological Information:No information available SECTION 13: Disposal Considerations Disposal:Dispose of according to local, state and federal regulations. SECTION 14: Transportation Shipping Name (CFR):Magnesium fluorosilicate Hazard Class (CFR):6.1 Additional Hazard Class (CFR):NA Packaging Group (CFR):III UN ID Number (CFR):UN# 2853 Shipping Name (IATA):Magnesium fluorosilicate Hazard Class (IATA):6.1 Additional Hazard Class (IATA):NA Packaging Group (IATA):III UN ID Number (IATA):UN# 2853 SECTION 15: Regulatory Information TSCA:Listed in the TSCA inventory. SARA (Title 313):Title compound not listed. Second Ingredient:none SECTION 16 - ADDITIONAL INFORMATION N/A |